Maynard Um
-
-
-
-
-
-
-
Theralase(R) Lists Warrants on the TSXV
-
-
-
-
-
-
-
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
-
-
-
-
-
-
-
Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
-
-
-
-
-
-
-
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
-
-
-
-
-
-
-
Theralase(R) Releases 2Q2025 Financial Statements
-
-
-
-
-
-
-
CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
-
-
-
-
-
-
-
Ruvidar Demonstrates 7 Year Complete Response
-
445,672 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

